Research Supervisor Connect
To compare national safety warnings on medicines in Australia, Canada, the European Union and the United States over a 10-year period, from 2007-2016, with follow-up research updates.
Camperdown - Charles Perkins Centre
Masters/PHD
Medicines have a key role in improving health and easing symptoms, but can also cause serious harm, and many harmful effects only become known once a medicine is in wide use.
When new safety concerns arise, governments often differ in whether or how they warn clinicians and the public. This is the first international comparison of the effectiveness of different approaches. The aim is to improve safety oversight.
This mixed method study includes a policy analysis, advisory content analysis, key informant interviews, and population-based analyses of prescribing effects. Applicants may focus on either qualitative or quantitative components.
This is a collaborative project with teams from University of British Columbia, Harvard, University of Utrecht, and University of South Australia. Some travel may be needed for data collection (if possible, depending on pandemic-related restrictions). This project currently has no external funding; interested students would therefore need to obtain their own fellowship funding.
The opportunity ID for this research opportunity is 2182